Vis enkel innførsel

dc.contributor.authorSteiner, Timothy J.
dc.contributor.authorStovner, Lars Jacob
dc.contributor.authorKatsarava, Zaza
dc.contributor.authorLainez, Jose Miguel
dc.contributor.authorLampl, Christian
dc.contributor.authorLanteri-Minet, Michel
dc.contributor.authorRastenyte, Daiva
dc.contributor.authorRuiz de la Torre, Elena
dc.contributor.authorTassorelli, Cristina
dc.contributor.authorBarre, Jessica
dc.contributor.authorAndree, Colette
dc.date.accessioned2019-11-07T06:57:32Z
dc.date.available2019-11-07T06:57:32Z
dc.date.created2014-11-19T23:17:17Z
dc.date.issued2014
dc.identifier.citationThe Journal of Headache and Pain. 2014, 15 (31)nb_NO
dc.identifier.issn1129-2369
dc.identifier.urihttp://hdl.handle.net/11250/2627055
dc.description.abstractBackground European data, at least from Western Europe, are relatively good on migraine prevalence but less sound for tension-type headache (TTH) and medication-overuse headache (MOH). Evidence on impact of headache disorders is very limited. Eurolight was a data-gathering exercise primarily to inform health policy in the European Union (EU). This manuscript reports personal impact. Methods The study was cross-sectional with modified cluster sampling. Surveys were conducted by structured questionnaire, including diagnostic questions based on ICHD-II and various measures of impact, and are reported from Austria, France, Germany, Italy, Lithuania, Luxembourg, Netherlands, Spain and United Kingdom. Different methods of sampling were used in each. The full methodology is described elsewhere. Results Questionnaires were analysed from 8,271 participants (58% female, mean age 43.4 y). Participation-rates, where calculable, varied from 10.6% to 58.8%. Moderate interest-bias was detected. Unadjusted lifetime prevalence of any headache was 91.3%. Gender-adjusted 1-year prevalences were: any headache 78.6%; migraine 35.3%; TTH 38.2%, headache on ≥15 d/mo 7.2%; probable MOH 3.1%. Personal impact was high, and included ictal symptom burden, interictal burden, cumulative burden and impact on others (partners and children). There was a general gradient of probable MOH > migraine > TTH, and most measures indicated higher impact among females. Lost useful time was substantial: 17.7% of males and 28.0% of females with migraine lost >10% of days; 44.7% of males and 53.7% of females with probable MOH lost >20%. Conclusions The common headache disorders have very high personal impact in the EU, with important implications for health policy.nb_NO
dc.language.isoengnb_NO
dc.publisherBioMed Centralnb_NO
dc.relation.urihttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045992/pdf/1129-2377-15-31.pdf
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleThe impact of headache in Europe: principal results of the Eurolight projectnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber11nb_NO
dc.source.volume15nb_NO
dc.source.journalThe Journal of Headache and Painnb_NO
dc.source.issue31nb_NO
dc.identifier.doi10.1186/1129-2377-15-31
dc.identifier.cristin1174948
dc.description.localcodeOpen Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.nb_NO
cristin.unitcode194,65,30,0
cristin.unitcode1920,16,0,0
cristin.unitnameInstitutt for nevromedisin og bevegelsesvitenskap
cristin.unitnameNevroklinikken
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal